NCT04106843 2020-09-07Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine CancersM.D. Anderson Cancer CenterPhase 2 Withdrawn